Conventional screening for prostate cancer is not ideal for differentiating more aggressive cancer from less aggressive disease. Quest hasjoined upwith Cleveland Diagnostics to broaden access to a novel lab test that may help providers grade prostate cancer to identify which patients are at greater risk...